Is STAAR Surgical Co halal to invest in?

According to Musaffa's Shariah screening methodology, STAAR Surgical Co (STAA) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is STAAR Surgical Co a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes STAAR Surgical Co using these criteria to determine its compliance status.

Can Muslims buy shares of STAAR Surgical Co?

Muslim investors may consider investing in STAAR Surgical Co if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is STAAR Surgical Co classified as HALAL?

Musaffa determines the Shariah status of STAAR Surgical Co by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for STAAR Surgical Co updated?

The Shariah compliance status of STAAR Surgical Co may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like STAAR Surgical Co become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of STAAR Surgical Co?

You can check the latest Shariah compliance status of STAAR Surgical Co on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

STAA Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: March 04, 2026

Report Source: 2025 Annual Report

STAAR Surgical Co. Stock Analysis STAA

United States Health Care Small Cap Report: 2025 Annual

STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The company is headquartered in Monrovia California, California and currently employs 957 full-time employees. The firm markets and sells its ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. Its EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The firm's newest offering, EVO Viva, has an extended depth of focus (EDoF) optic, which is designed to treat myopia with presbyopia (age-related loss of ability to focus). The company also market and sell an ICL lens to treat hyperopia (farsightedness), called Visian ICL. The company makes its ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision). The Company’s principal products are ICLs used in refractive surgery, including its EVO family of lenses.

Key Statistics of STAAR Surgical Co (STAA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$31.15$33.05

Today's Open

$32.00

Volume

1.37M

P/E Ratio (TTM)

52 Week Range

$15.59$35.87

Market Cap

1.36B

Avg. Volume

890.96K

Dividend Yield

Financial Metrics & Statements of STAAR Surgical Co (STAA)

FAQ's for STAAR Surgical Co (STAA)

According to Musaffa’s Shariah screening methodology, STAAR Surgical Co (STAA) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.